 |
| Muscle Spasticity Market |
Market Overview
Muscle spasticity refers to the tightening or stiffening of muscles which
restricts movement. It is a common symptom resulting from damage to motor
neurons in the brain or spinal cord, often due to conditions like cerebral
palsy, multiple sclerosis, spinal cord injury or stroke. The key products and
services used for managing muscle spasticity includes botulinum toxin
injections, physical & occupational therapy, muscle relaxant drugs and
antispasticity devices. With the increasing cases of neurological conditions
globally, the demand for treatment of muscle spasticity is growing.
The Global Muscle Spasticity Market is estimated to be
valued at US$ 5693.7 Mn in 2024 and
is expected to exhibit a CAGR of 11% over
the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Muscle Spasticity market are Accenture PLC,Cisco
Systems Inc.,Cognizant Technology Solutions Corporation,Capgemini,Computer
Sciences Corporation (CSC),HCL Technologies Ltd.,IBM Corporation,Infosys
Ltd.,Intel Corporation,Jabil Circuits,Micron Technology,NTT Data
Corporation,Tata Consultancy Services,Tech Mahindra Ltd.,Wipro Ltd. These
players are focusing on developing innovative spasticity management options
like combination drug therapies and neurostimulation devices.
There is high potential for growth in emerging economies due to increasing
healthcare expenditure and growing patient awareness. Various Muscle
Spasticity Market Growth players are undertaking strategic
collaborations and partnerships to expand their presence in high growth regions
like Asia Pacific and Latin America. For instance, Merz Pharma collaborated
with Anthropic to utilize artificial intelligence techniques for development of
new treatment options.
Key opportunities in the market include strategic mergers and acquisitions of
emerging players offering novel treatment modalities. Companies are also
investing heavily in R&D to develop patient specific therapies, monitor
treatment response and develop disease modifying approaches.
Market Drivers
The key driver for the muscle spasticity market is rising prevalence of
neurological disorders globally. As per WHO, over 1 billion people suffer from
neurological conditions worldwide annually. Conditions like cerebral palsy,
multiple sclerosis and spinal cord injuries often lead to muscle spasticity
symptoms, thereby increasing the patient pool for treatment options.
Market Restrain
High cost of approved drug therapies and lack of healthcare infrastructure in
developing regions is a major challenge restraining market growth. Botulinum
toxin injections which are the front line treatment cost over US$5000 per
session posing affordability issues. Physical therapy sessions also add to the
overall treatment cost burden for patients. Lack of awareness amongst patients
about available treatment options also limits the market demand for spasticity
management globally.
Segment Analysis:
The muscle spasticity market can be segmented as type of treatment, type of
muscles affect and end users. Based on treatment type, the botulinum
neurotoxins sub segment holds the major share and is dominating the market.
Botulinum neurotoxins are used to reduce muscle stiffness and spasms caused by
conditions like cerebral palsy, spinal cord injury, multiple sclerosis etc. Due
to their effective long lasting results and minimal side effects, botulinum
neurotoxins are highly preferred choice of treatment among physicians and
patients. Among muscle types, lower limb muscle spasticity sub segment holds
the largest share. This is because spasticity in lower limbs severely affects
mobility and causes discomfort.
Global Analysis:
Regionally, North America region dominates the muscle spasticity market
currently. This is due to high availability of advanced treatment options,
presence of major manufacturers, rising awareness about therapies and favorable
reimbursement policies in countries like US and Canada. Europe region captures
the second largest market share owing to growing geriatric population,
increasing prevalence of neurological disorders and government support for
research. Asia Pacific region is expected to witness highest growth during
forecast period. This growth can be attributed to rapidly developing healthcare
infrastructure, rising medical tourism, growing incidence of cerebral palsy and
stroke cases. Growing economies of India and China provide huge patient
population and increase adoption of new treatment technologies.
Get More Insights On This Topic: Muscle
Spasticity Market